Psoriasis: all 1,928 studies
Page 16 of 20. Open to participants first (234), then studies with results posted, then the rest; newest registration first within each.
- An Observational Monocentric Study Investigating the Association Between Trough Serum Levels of Etanercept, Antibodies Towards Etanercept and Its Effectiveness in Psoriasis PatientsCompletedNCT02322580
- A Phase 2 Study of Cellular and Immunologic Changes in the Skin of Subjects Receiving PH-10CompletedNCT02322086Phase 2
- Optimizing Psoriasis Treatment of Etanercept Combined MethotrexateCompletedNCT02313922Phase 4
- Therapeutic Education Program in PsoriasisCompletedNCT02310204Not applicable
- Cytokines and Vascular Inflammation in PsoriasisCompletedNCT02305953
- Study to Assess Safety, Tolerability, Pharmacokinetic & Pharmacodynamic Effect of UCB5857 in Healthy & Psoriatic SubjectCompletedNCT02303509Phase 1
- A Study to Evaluate Safety and Efficacy of Toreforant (JNJ-38518168) in Participants With Moderate to Severe Plaque-type PsoriasisCompletedNCT02295865Phase 2
- A Study to Assess the Severity of Psoriasis in Brazilians Participants With Chronic Plaque-type PsoriasisCompletedNCT02274363
- Effect of Vitamin D Supplementation on Metabolic Parameters of Patients With PsoriasisCompletedNCT02271971Not applicable
- Safety and Efficacy of Etanercept in Patients With PsoriasisStatus unknownNCT02258282Not applicable
- Evaluate the Effect of Elimune CapsulesCompletedNCT02251678Phase 1
- Quality of Life of Patients With Psoriasis Treated With Methotrexate: Prospective, Randomized, Double-blind, Parallel Group Study.Status unknownNCT02248792Phase 4
- Safety and Tolerability Study of COVA322 in Patients With Stable Chronic Moderate-to-severe Plaque PsoriasisTerminatedNCT02243787Phase 1/2
- Observational Study to Estimate the Effectiveness of Biologics When Treating Plaque PsoriasisCompletedNCT02239666
- Efficacy and Safety of Tazarotene Gel in Nail PsoriasisCompletedNCT02235480Phase 2
- A Study of Multiple Doses of AbGn-168H by Intravenous Infusion in Patients With Moderate to Severe Chronic Plaque PsoriasisCompletedNCT02223039Phase 2
- BIRB 796 BS Versus Placebo in Patients With Moderate to Severs Plaque-type PsoriasisCompletedNCT02209753Phase 2
- Haut-Tief Patient Education on Psoriasis and EczemaStatus unknownNCT02205593Not applicable
- A Single-Center, Prospective, Pilot Study to Compare the Effect of Diet in Overweight or Obese Patients With Psoriasis on Light TherapyCompletedNCT02193919
- Efficacy and Safety Study of Total Glucosides of Paeony Combined With Acitretin to Treat PsoriasisCompletedNCT02191020Not applicable
- Efficacy and Safety Study of Calcipotriol Betamethasone Plus Calcipotriol in Sequential Therapy to PsoriasisCompletedNCT02191007Not applicable
- A Intra-individual Comparison to Investigate the Efficacy and the Safety of LAS41004 Formulation in Mild to Moderate PsoriasisCompletedNCT02180464Phase 2
- An Observational Cohort Study Evaluating Fatty Liver Disease and Liver Fibrosis in Moderate to Severe PsoriasisStatus unknownNCT02174367
- Methotrexate Polyglutamates as a Marker of Clinical Response and Toxicity in the Treatment of PsoriasisStatus unknownNCT02174354
- Reduction of Pain Caused by Biologic Drugs in PsoriasisCompletedNCT02168244Not applicable
- Excimer Laser, Serum Markers & PsoriasisWithdrawnNCT02165657Not applicable
- Videocapillaroscopy Assessment During Systemic Agent Therapy in PsoriasisCompletedNCT02162472
- Generic Tazarotene Cream, 0.05% for the Treatment of Plaque PsoriasisCompletedNCT02160665Phase 3
- An Exploratory Genetic Study in Participants With PsoriasisCompletedNCT02155192
- Clinical Trial of PSORI-CM01（YXBCM01） Granule to Treat Stable Plaque PsoriasisTerminatedNCT02153840Not applicable
- The NOR-SWITCH StudyCompletedNCT02148640Phase 4
- Therapeutic Drug Monitoring of Adalimumab in Psoriasis PatientsCompletedNCT02147600
- LP0058-1005 - A Open-Label, Four-Way Crossover and Food-Effect Study of LEO 32731 in Healthy SubjectsCompletedNCT02126371Phase 1
- Comparing Mindfulness Based Cognitive Therapy and Mindfulness Based Self-compassion Therapy in a Psoriasis SampleStatus unknownNCT02122978Not applicable
- ASIS for Enbrel in Plaque PsoriasisStatus unknownNCT02112097Phase 1/2
- Efficacy, Tolerability and Safety of LAS41004 Formulations in a Psoriasis Plaque TestCompletedNCT02111499Phase 1/2
- Bioequivalence and Pharmacokinetic Study of Prurisol™ and Abacavir Sulfate in Healthy VolunteersCompletedNCT02101216Phase 1
- Evaluation of Spa Therapy in the Treatment of Plaque PsoriasisCompletedNCT02098213Not applicable
- Bioavailability in Patient With Psoriasis: Metoject Prefilled PenCompletedNCT02097173Phase 1
- Mechanistic Study of Indigo Naturalis in Treating PsoriasisCompletedNCT02088281Phase 2
- IL-17 Role in Variants of PsoriasisCompletedNCT02078297
- A Phase 3 Clinical Study of KHK 4827CompletedNCT02052609Phase 3
- Randomized, Blinded, Sham-controlled Trial of Acupuncture for the Management of Joint Pain in Patients With PsoriasisTerminatedNCT02047851Not applicable
- P Wave and QT Dispersion in PsoriasisCompletedNCT02045485
- TSO for Plaque PsoriasisWithdrawnNCT02011269Phase 2
- Study for Treatment With Calcipotriol/Betamethasone Dipropionate Gel in Korean Patients With Psoriasis VulgarisCompletedNCT02004574Phase 4
- A Safety and Efficacy Study of DRM02 in Subjects With Plaque PsoriasisCompletedNCT01993433Phase 2
- Efficacy Study Comparing Topical M518101 and Vitamin D3 in Adult Psoriasis PatientsCompletedNCT01989429Phase 3
- Dose-finding Study of MT-1303 in Subjects With Moderate to Severe Chronic Plaque PsoriasisCompletedNCT01987843Phase 2
- A Study to Evaluate the Irritation Potential of GSK2894512 Cream on Skin in Healthy SubjectsCompletedNCT01984775Phase 1
- An Observational Study to Assess Patient Satisfaction and Control of Psoriasis With Calcipotriene/Betamethasone Dipropionate (Taclonex®) Topical Suspension, and Effect on Quality of LifeCompletedNCT01982552
- Clinical Assessment and Psychosocial Impact of PsoriasisCompletedNCT01964443
- Efficacy Study of Trichuris Suis Ova to Treat Chronic Plaque PsoriasisTerminatedNCT01948271Phase 1
- T and B Cell Responses in Autoimmune DiseasesTerminatedNCT01947036
- A Vasoconstriction Study With LEO 90100CompletedNCT01946386Phase 1
- Study Comparing AM001 Cream to Vehicle in the Treatment of Plaque PsoriasisCompletedNCT01938599Phase 2
- A Study to Evaluate the Efficacy and Safety/Tolerability of Subcutaneous MK-3222 in Participants With Moderate-to-Severe Chronic Plaque Psoriasis (MK-3222-012)WithdrawnNCT01936688Phase 3
- Topical Double-blind, Randomized, Placebo-controlled Study in Psoriasis PatientsCompletedNCT01936337Phase 2
- Combined Cumulative Irritation Potential and Repeat Insult Patch Test of LEO 90100CompletedNCT01935869Phase 1
- At-Home Research Study for Patients With Autoimmune, Inflammatory, Genetic, Hematological, Infectious, Neurological, CNS, Oncological, Respiratory, Metabolic ConditionsCompletedNCT01931644
- Comparative Analysis of Small and Large Plaque PsoriasisCompletedNCT01920906Not applicable
- Parallel Group Trial to Evaluate the Efficacy and Safety of Loion® Compared to 10% Salicylic Acid in Patients With Chronic Psoriasis CapitisCompletedNCT01914627Phase 2
- Long Term Study to Evaluate Safety and Efficacy of M518101 in Subjects With Plaque PsoriasisCompletedNCT01908595Phase 3
- Evaluation of Vitamin D Levels in Psoriasis PatientsWithdrawnNCT01903317
- A Study of Topical Indigo Naturalis Treatment in Patients With Mild to Moderate Plaque-type PsoriasisCompletedNCT01901705Phase 2
- Efficacy and Safety Study of Subcutaneous Secukinumab in Treatment of Subjects With Moderate to Severe Chronic Plaque-type Psoriasis as Compared to Etanercept and Placebo.WithdrawnNCT01900782Phase 3
- A Study to Evaluate the Pharmacokinetics (PK), Safety and Tolerability, Immunogenicity, and Pharmacodynamics (PD) of GSK2800528 in Healthy Subjects.CompletedNCT01899755Phase 1
- Autologous Cytokine Induced Killer Cells (CIK) for Patients With Severe PsoriasisCompletedNCT01894373Phase 1/2
- Thalidomide in the Treatment of Chronic Plaque Psoriasis.CompletedNCT01891019Phase 2
- Evaluate the Efficacy and Safety of M518101 in Subjects With Plaque PsoriasisCompletedNCT01878461Phase 3
- n-3 Polysaturated Fatty Acids-rich Diet in PsoriasisCompletedNCT01876875Phase 4
- Study to Evaluate the Efficacy and Safety of M518101 in Subjects With Plaque PsoriasisCompletedNCT01873677Phase 3
- Pilot Study Characterizing Adipose Tissue Leukocytes by Flow Cytometry/Microscopy in Lean, Obese and Psoriatic SubjectsTerminatedNCT01856647
- Phase IIa Study of Multiple Doses of AbGn-168H by iv Infusion in Moderate to Severe Chronic Plaque Psoriasis PatientsCompletedNCT01855880Phase 2
- A Study of the Efficacy, Safety and Tolerability of CNTO 1959, a Human Anti-IL 23 Monoclonal Antibody in Participants With Palmoplantar PustulosisCompletedNCT01845987Phase 2
- Study to Evaluate the Pharmacokinetics and the Safety of M518101 in Plaque Psoriasis PatientsCompletedNCT01844973Phase 1
- An Exploratory Psoriasis Plaque Test Study With Different Dose Combinations of Calcipotriol Plus Betamethasone Dipropionate in the Daivobet® Gel Vehicle in Psoriasis VulgarisCompletedNCT01837576Phase 1
- A Study to Evaluate the Efficacy and Safety of VB-201 in Patients With PsoriasisCompletedNCT01837420Phase 2
- Safety and Effectiveness of CNDO 201Trichuris Suis Ova (TSO) for the Treatment of Moderate to Severe Plaque PsoriasisCompletedNCT01836939Phase 1
- Single and Multiple Dose Escalation Study to Assess the Safety and Tolerability of CJM112 in PsoriasisCompletedNCT01828086Phase 1
- Efficacy Study on Dimethyl Fumarate to Treat Moderate to Severe Plaque PsoriasisWithdrawnNCT01815723Phase 3
- Economic Evaluation of Systemic Treatments for Moderate-to-severe PsoriasisCompletedNCT01812954
- OTIS Cimzia Pregnancy RegistryActive, not recruitingNCT01797224
- An Open-label, Non-controlled Study of KHK4827 in Subjects With PsoriasisCompletedNCT01782937Phase 3
- A Phase 3 Clinical Study of KHK4827CompletedNCT01782924Phase 3
- Immune Signature of Palmoplantar PustulosisCompletedNCT01780857
- The Psoriasis, Atherosclerosis, and Cardiometabolic Disease Initiative (PACI)CompletedNCT01778569
- Treatment of Palmoplantar Psoriasis With Low Doses Interferential CurrentCompletedNCT01765985Phase 2/3
- Nicotinamide in the Treatment of PsoriasisCompletedNCT01763424Phase 2/3
- Post Marketing Observational Study on Venezuelan Patients With PsoriasisWithdrawnNCT01758705
- Analysis Of The Influence Of Metabolic Syndrome On Treatment Efficacy With Anti-Tnf In Moderate-Severe Psoriasis In Real Clinical Practice.Status unknownNCT01753245
- A Phase 2 Clinical Study of KHK4827CompletedNCT01748539Phase 2
- TL1A Expression in Psoriatic SkinStatus unknownNCT01744327
- Antipsoriatic Effect of a Topical Formulation for the Treatment of Psoriasis VulgarisCompletedNCT01743118Phase 1
- Dosage Determination Trial for Indigo Naturalis Extract in Oil OintmentCompletedNCT01735864Not applicable
- LAS41008 in Moderate to Severe Chronic Plaque PsoriasisCompletedNCT01726933Phase 3
- Cromoglicate in PsoriasisCompletedNCT01722812Phase 2
- Trial on the Effect of Adalimumab on Vascular Inflammation in Patients With PsoriasisCompletedNCT01722214Phase 4
- Efficacy Study of Dietary Intervention and Weight Loss in Improving PsoriasisCompletedNCT01714284Not applicable
- A Study to Assess the Relative Bioavailability of New Oral Formulations of SRT2104 in Healthy Male VolunteersCompletedNCT01702493Phase 1